Physician profile
Jacob M Clapper
NPI 1730677238
$7,579.98
in general payments reported to CMS, 2019-2025
41 companies · $2,670 in 2025
The $2,670 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $713 · 2022: $957 · 2023: $877 · 2024: $2,363 · 2025: $2,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,579 · Travel and Lodging: $1,041 · Education: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,579.29 |
| Travel and Lodging | $1,041.02 |
| Education | $289.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,081.66 | 2021-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $625.18 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $575.55 | 2021-2025 | Erleada, Akeega |
| Abbvie INC. | $574.56 | 2021-2025 | |
| Pfizer INC. | $264.73 | 2021-2025 | |
| Coloplast Corp | $259.11 | 2021-2025 | Speedicath, Altis |
| Antares Pharma, INC. | $237.58 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Medtronic, INC. | $233.30 | 2021-2025 | Altaviva, Interstim |
| Janssen Scientific Affairs, LLC | $227.26 | 2023-2025 | Erleada, Pipeline |
| Astellas Pharma US INC | $208.45 | 2021-2025 | Xtandi, Veozah |
| Olympus America INC. | $204.06 | 2021-2025 | Itind System |
| Myovant Sciences INC. | $188.17 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $181.31 | 2021-2025 | Prolaris |
| Dendreon Pharmaceuticals LLC | $160.46 | 2023-2025 | Provenge |
| Ferring Pharmaceuticals INC. | $149.86 | 2024-2025 | Adstiladrin |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $135.27 | 2021-2025 | Posluma |
| Urovant Sciences INC | $125.05 | 2022 | |
| Boston Scientific Corporation | $102.03 | 2023-2025 | General - Erectile Dysfunction, Axonics |
| Tolmar, INC. | $93.34 | 2023-2025 | |
| Seagen INC. | $84.99 | 2025 | |
| Amgen INC. | $84.13 | 2022-2023 | Xgeva, Prolia |
| Intuitive Surgical, INC. | $72.13 | 2022 | |
| Allergan, INC. | $65.70 | 2021 | |
| Calyxo, INC. | $65.54 | 2025 | Cvac Aspiration System |
| Axonics, INC. | $60.11 | 2022-2023 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $58.75 | 2022-2025 | |
| Travere Therapeutics, INC. | $51.75 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $50.18 | 2025 | Lynparza |
| Urogen Pharma, INC. | $44.25 | 2023-2025 | Jelmyto |
| C. R. Bard, INC. & Subsidiaries | $44.24 | 2024-2025 | Personal Catheter Intermittent Catheter |
| Progenics Pharmaceuticals, INC. | $42.16 | 2023-2024 | Pylarify |
| Convatec INC. | $31.18 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $28.83 | 2021-2022 | |
| Telix Pharmaceuticals | $28.66 | 2022 | |
| Immunitybio, INC. | $23.76 | 2025 | |
| Procept Biorobotics Corporation | $23.50 | 2024 | Aquabeam System |
| Valencia Technologies Corporation | $23.49 | 2025 | Ecoin Device Kit |
| Laborie Medical Technologies Corp. | $19.09 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Abc Home Medical Supply, INC. | $18.83 | 2025 | |
| Angiodynamics, INC. | $17.67 | 2025 | Nanoknife |
| Halozyme INC | $14.11 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Clapper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.